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Abstract
Background: Chytridiomycosis is a fungal disease linked to local and global extinctions of amphibians. Susceptibility to
chytridiomycosis varies greatly between amphibian species, but little is known about between- and within-population
variability. However, this kind of variability is the basis for the evolution of tolerance and resistance evolution to disease.
Methodology/Principal Findings: In a common garden experiment, we measured mortality after metamorphosis of Alytes
obstetricans naturally infected with Batrachochytrium dendrobatidis. Mortality rates differed significantly among populations
and ranged from 27 to 90%. Within populations, mortality strongly depended on mass at and time through metamorphosis.
Conclusions/Significance: Although we cannot rule out that the differences observed resulted from differences in skin
microbiota, different pathogen strains or environmental effects experienced by the host or the pathogen prior to the start
of the experiment, we argue that genetic differences between populations are a likely source of at least part of this
variation. To our knowledge, this is the first study showing differences in survival between and within populations under
constant laboratory conditions. Assuming that some of this intraspecific variation has a genetic basis, this may suggest that
there is the potential for the evolution of resistance or tolerance, which might allow population persistence.
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Introduction
Emerging infectious diseases can represent an important threat
to biodiversity and wildlife [1]. Although extinction by disease is a
rare event and unlikely in most systems, certain conditions can
increase the risk of local or even global extinction by disease: a
sympatric host that acts as a reservoir for the pathogen, disease
transmission that is frequency-dependent, or disease that drives
local populations to such low densities that stochastic factors
become important [2].
Chytridiomycosis, a disease caused by the chytrid fungus
Batrachochytrium dendrobatidis (Bd hereafter), is a disease of amphib-
ians that may cause extinctions because it fulfils all three
conditions: It infects a variety of hosts with different susceptibil-
ities, some of them acting as reservoirs [3], transmission is
frequency-dependent at low densities [4], and amphibians often
occur in small populations that are prone to stochastic effects [5].
Accordingly, chytridiomycosis has been linked to local and global
extinctions of amphibians in Central America, Australia and
Europe since its discovery in 1998 [6].
Susceptibility to Bd and chytridiomycosis varies greatly among
amphibian species [7] and much research has been devoted to the
identification of the causes of this variability (e.g. [8,9,10]). This
line of research helps to identify which species are at risk from Bd
[11]. While some species seem to have disappeared completely
following Bd invasion [12], populations of other species have
persisted [13,14,15], suggesting that there is variation in
susceptibility to disease within species. Here we focus on within-
species variation in susceptibility to chytridiomycosis because this
kind of variability is the raw material for the possible evolution of
resistance or tolerance [16] to Bd, and hence population
persistence [17,18,19]. As no methods are available yet to treat
amphibian populations in the field against Bd, susceptible species
may persist only where conditions are not favourable for Bd or for
disease outbreaks [20,21], or when they can evolve an evolution-
ary response to the threat imposed by the emergence of
chytridiomycosis. The latter may include evolutionary change in
defensive skin peptides. Nevertheless, only few studies have
addressed within-species variation in susceptibility to this disease
and none has looked at the genetic basis of this variation [7,22,23].
One of the species that is known to be highly susceptible to
chytridiomycosis is the common midwife toad, Alytes obstetricans.
The species is widespread across Europe and has suffered
substantial declines throughout its range [24]. It was the first
species to decline in Europe as a result of mass die-offs after the
emergence of Bd [25]. In Spain, mortality almost exclusively
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adults are strongly terrestrial and have a low risk of infection.
Chytridiomycosis-induced mortality is strongly associated with
cold and moist conditions at the time of metamorphosis [20,21].
Midwife toads have also suffered strong declines in Switzerland,
where more than 50% of the populations went extinct over the last
quarter century [26]. Bd is present and widespread in Switzerland
([27], U. Tobler & B. R. Schmidt, unpublished data).Yet, in the
field, no mass mortality has been observed. Only four dead
metamorphs were found in the field so far, all of which exhibited
high zoospore loads as determined by rt-PCR (B. R. Schmidt & U.
Tobler, unpublished data).
The aim of our study was to quantify the impact of Bd and
variation thereof on midwife toad populations by measuring post-
metamorphic survival of infected individuals in a common garden
laboratory experiment. We demonstrate that Bd is linked to
mortality under laboratory conditions and that mortality varies
greatly among populations. We also identify correlates of mortality
among individuals within populations.
Materials and Methods
Study sites
We collected one-year old tadpoles of Alytes obstetricans shortly
after hibernation in 2008 from three sites in Switzerland, two of
which were located in canton Baselland and one in canton St.
Gallen. Standard hygiene protocols were followed during field
work to avoid the spread of Bd and other pathogens [28]. The sites
were chosen because 1) we knew they sustained large tadpole
numbers and 2) they were positive for Bd [28]. The first site in
Baselland (7.783306uE, 47.459667uN, 410 masl, hereafter referred
to as BLI) is located in a former quarry and consists of three main
water bodies, in only two of which tadpoles were caught. The
larger pond is about 16 m
2 in size, 0.8 m deep and is densely
vegetated; the smaller pond is 8 m
2 in size, 0.5 m in depth, and
has very little vegetation but has reed along the edges. The second
site in Baselland (7.801185uE, 47.436677uN, 480 masl, hereafter
referred to as BLZ) is a forest pond approximately 300 m
2 in size
and 2.5 m in depth. The site in St. Gallen (9.533416uE,
47.381742uN, 540 masl, hereafter referred to as SGA) is a garden
at the south-eastern distribution border of the species. The
population is larger than 20 calling males, and three small garden
ponds (2–5 m
2 in size, 0.2–0.5 m in depth) serve as breeding sites.
Laboratory experiment: treatments
Bd only infects keratinised skin of amphibians [29] and infection
in tadpoles is restricted to the mouthparts, which does not cause
disease. However, during metamorphosis, the skin becomes
keratinised, and the pathogen can then spread over the whole
body and cause hyperkeratosis and osmotic imbalance, leading to
death [30,31]. Recently metamorphosed individuals are most
susceptible to disease, supposedly due to a downregulation of
immune defences during metamorphosis [32]. Thus, we measured
differences in post-metamorphosis survival of Bd-positive and -
negative Alytes tadpoles from the three populations. Because all
tadpoles were tested for Bd infection with rt-PCR [33] and
confirmed positive initially, we assigned them to three different
treatments in order to obtain one Bd-negative control: 1) The
‘‘Itraconazole treatment’’ group served as a Bd-free control.
Individuals were treated with Itraconazole (1 mg/L; Sporanox,
Janssen-Cilag) for 5 minutes per day over the course of seven days
to clear the infection. We followed the protocol developed by
Garner et al. [34] which had been successfully used for the
treatment of Alytes muletensis tadpoles against Bd; unlike Garner
et al. [34], we observed no depigmentation. The tadpoles were
returned to the same container after treatment, which had been
rinsed with boiling water during the Itraconazole bath. 2) Because
the tadpoles were exposed to low water levels and frequent capture
during the Itraconazole treatment, we designed the ‘‘infected
handled treatment’’ as a control for stress during handling. The
tadpoles were treated in exactly the same way as the Itraconazole
treatment, but instead of an Itraconazole solution, tap water was
used. 3) The ‘‘infected unhandled’’ group was not handled apart
from the regular water change and feeding and was left infected
throughout the experiment.
To test for differences in survival among populations, we
assigned equal numbers of tadpoles from the three populations to
the three treatments. We balanced body mass among treatments
within populations.
Laboratory experiment: procedures
We caught 143 tadpoles (50 from BLI, 43 from BLZ and 50
from SGA) in April 2008 and brought them to the laboratory,
where they were placed in individual one-litre plastic containers
filled with tap water and a single dried beech tree (Fagus sp.) leaf.
The laboratory was equipped with full spectrum sunlight lamps,
and we used a daylength of 16 hours and kept the room at 19–
21uC. Throughout the course of the experiment, we changed the
water in the containers twice a week and added food containing
Spirulina algae (Tetra Pleco Wafer, Tetra Germany, Spectrum
Brands Inc.) ad libitum three times a week. In the week following
capture, the tadpoles were weighed to the nearest 0.01 g (Scaletec
Instruments, Heiligenstadt, Germany), measured from the snout to
the beginning of the tail muscle to the nearest 0.1 mm, and
swabbed over the mouth parts with a sterile cotton swab (Copan
Italia S.p.A., Brescia, Italy). Further swabs were taken when
metamorphosis was finished (Gosner stage 46, [35]) and (3) upon
death or 30 days after stage 42. Size measurements were repeated
three times during the experiment: (1) when the larvae entered
metamorphosis (Gosner stage 42), (2) when metamorphosis was
finished (Gosner stage 46) and (3) upon death or 30 days after stage
42. We used separate pairs of gloves for handling and separate
plastic beakers for weighing each tadpole. When the tadpoles
entered metamorphosis (Gosner stage 42), the containers were
drained of most of the water and tilted, so that both land and
water were available to the toadlets. We put a moist paper towel at
the bottom of each container. When the metamorphosis was
complete (Gosner stage 46), we fed the toadlets crickets of
adequate size ad libitum three times a week. For each individual, the
experiment was ended 30 days after stage 42 or upon death.
rt-PCR
We analysed the swabs for the presence of Bd with Bd-specific
primers in rt-PCR following the protocol by Boyle et al. [33] with
slight modifications: samples were run in duplicates and when the
two PCR-wells retuned inconsistent results, the analysis was
repeated. Because the extraction reagent is inhibitory to the PCR
reaction, samples were diluted 1:10 prior to rt-PCR analysis. As in
Boyle et al. [33], we report untransformed zoospore equivalents.
Reactions yielding 0.1 genomic equivalents (GE; untransformed
value) or above were considered Bd-positive. This threshold was
used to classify individuals as either ‘‘infected’’ or ‘‘not infected’’.
For the statistical analyses, however, we used zoospore loads rather
than the categories ‘‘infected’’ or ‘‘not infected’’.
Statistical analyses
We tested for differences in body length among the different
populations at three stages during development: at the beginning
Disease-Induced Mortality
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stage 46 (end of metamorphosis) using separate ANOVA, and we
tested for correlations between body mass and length at stage 42,
46 and the end of the experiment. Because mass and length were
strongly correlated, we only used body mass for subsequent
analyses.
To analyse survival data we used the Cox proportional hazard
model. This model assumes an underlying hazard function
describing how hazard changes over time, and fits effect
parameters using Cox’s likelihood. Individual survival times are
censored, which means that individuals may die after the end of
the study period. We tested for overall differences in mortality
between treatments and populations using daily counts on the
number of survivors until 30 days after beginning of metamor-
phosis (Gosner stage 42). To test for the effects of individual
condition and environmental effects on hazard risk, we did a Cox
proportional hazard model with the two infected treatments only.
The variables on individual condition included were body mass at
the beginning of the experiment, at stage 42, 46 and at the end or
death, and time through metamorphosis; the variables for
environmental effects were zoospore loads at the beginning, at
stage 46, at the end and time to metamorphosis. We also included
interactions between zoospore loads and population.
Because individuals that survived until the end of the
experiment had more time to gain mass, we tested the correlation
between body mass and time since metamorphosis with a Pearson
correlation test. All tests were performed in R, version 2.8.1 [36].
Results
Populations differed significantly in body mass at the beginning
the experiment (ANOVA for mass at beginning of the experiment
and at stage 42: both p,0.001) but not at metamorphosis
(ANOVA at stage 46: p=0.144; Figure 1). Body length and mass
were strongly correlated at all stages (Pearson correlation
for beginning, stage 42, stage 46 and end of experiment;
rbeginning=0.83, rstage_42=0.76, rstage_46=0.30, rend=0.90; all
p,0.001).
Figure 1. Differences in body mass between populations. Boxplots showing body mass of the different populations at the beginning of the
experiment, at the start of metamorphosis (Gosner stage 42) and at the end of metamorphosis (Gosner stage 46). The black line represents the
median, the box represents the interquartile range containing 50% of the values, and whiskers mark the 1.5 fold interquartile range. Outliers are
marked with circles. Grey boxes=survivors, white boxes=non-survivors.
doi:10.1371/journal.pone.0010927.g001
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time of capture. When they completed metamorphosis (Gosner
stage 46), all Itraconazole-treated tadpoles were Bd-negative
while all infected unhandled or infected handled tadpoles were
still infected. Eight tadpoles died during the course of the
experiment before undergoing metamorphosis: Two tadpoles
from BLI died before treatment assignment within a week after
capture, and another tadpole from BLI died in the unhandled
group. Two tadpoles from BLZ died in the Itraconazole group,
and from SGA one tadpole died in the Itraconazole treatment
and two from the infected handled treatment, the last five all
within 1.5 weeks after treatment. Because chytridiomycosis
usually does not cause mortality during the larval stage and most
deaths were probably caused by transportation or handling
stress, these 8 tadpoles were excluded from the analyses. The
remaining 135 tadpoles reached Gosner stage 42 (beginning of
metamorphosis) 25 to 129 days after 25 April, when the first
swab was collected (and 32–136 days after capture). From stage
42 on, it took them seven to 18 days (mean6SD: 1262) to fully
resorb the tail.
All Itraconazole-treated toadlets survived until the end of the
experiment; mortality only occurred in infected toadlets. Across all
populations, only 34.1% (31 out of 90) of infected (handled and
unhandled) metamorphs survived until 30 days after stage 42;
those that died survived on average for 8.666.5 days post-
metamorphosis only.
Infected animals that died showed disease symptoms typical
of chytridiomycosis shortly before death [37]. Diseased individ-
uals stopped feeding approximately one day prior to death but
did not show any other symptoms until less than a day before
they died. Only within a few hours to death they would become
lethargic and loose their righting reflex, at the same time they
started to shed skin heavily when touched. Although we did not
investigate dead individuals histologically to confirm that
chytridiomycosis was the cause of death, disease symptoms
and severity of infection as quantified by rt-PCR shortly before
or after death, respectively, suggest that chytridiomycosis was
the cause of death.
The Cox proportional hazard test revealed a significant effect
of treatment (p,0.001) and population (p,0.001) on survival
(Figure 2). Survival differed between infected and uninfected
individuals, but not between the infected unhandled and the
infected handled group (unhandled: 33.5629.1%, handled:
32.6643.9%). Population BLI differed from the two other
populations in survival among infected individuals (i.e. confi-
dence intervals did not overlap; BLI: 7562.0% (SE), BLZ:
14.661.9%, SGA: 9.660.7%), but there was no difference in
survival between SGA and BLZ. Because the handled and
unhandled group did not differ in survival, they were pooled for
subsequent analyses.
In the infected treatment groups, heavier individuals survived
better (Cox proportional hazard test, Figure 3, Table 1); body
mass at the end of the experiment strongly correlated with life span
since stage 46 (Pearson correlation, p,0.001). Survivors complet-
ed metamorphosis slightly slower than individuals that died later
on (survivors: 12.962.8 (SD) days, non-survivors: 12.362.6 days,
Table 1). Although infection load at any stage did not affect
individual hazard risk (Cox proportional hazard test, Table 1),
non-survivors had on average higher zoospore loads (9701
GE621726.2) than survivors (28.2 GE6113.2; Figure 4) at death
or at the end of the experiment, respectively. There was an
interaction between zoospore load and population (Table 1,
Figure 4). Three individuals out of 31 survivors had cleared
infection below the detection threshold.
Discussion
Here we show that under laboratory conditions, mortality in Bd-
infected metamorphs was population-specific and varied from
27% to 90%. Our experiment thus confirms that Bd infection was
linked to substantial mortality in Alytes toadlets from populations
where no mass mortality events caused by chytridiomycosis have
been reported even though Bd is widespread ([27], U. Tobler and
B. R. Schmidt, unpublished data). If the observed mortality is
representative of Bd-induced mortality in the field, such high levels
of mortality may lead to population declines [38,39].
How could such populations persist? Sensitivity analyses of
amphibian life histories suggest that post-metamorphic juvenile
survival appears to determine the fate of the populations. High
levels of mortality may lead to population declines [38,39]. In
contrast, Briggs et al. [13] modelled the effects of Bd on population
dynamics and predicted population persistence if some infected
individuals survive. Because no data on population trends are
available for the populations that we studied, we cannot tell
whether they currently undergo declines. To predict the fate of our
study populations, more data would be necessary. For example, it
is unknown (1) for how long Bd has been present in these
populations, (2) how long after the onset of chytridiomycosis the
adult populations are expected to decline, (3) whether and how
strongly mortality rates differ between years and (4) whether
density dependence in the adult stage could dampen the effects of
Bd-associated mortality immediately after metamorphosis.
To our knowledge, this is the first study to show differences in
the survival of Bd-infected individuals both within and between
populations in the laboratory. We do not know why individuals
and populations differed in susceptibility. Some variation may be
attributable to variation among individuals in growth (i.e., mass at
metamorphosis) and development (i.e., duration of metamorpho-
sis; [40], Table 1 and Figure 3), although the large difference in
body mass at the end of the experiment mostly resulted from the
Figure 2. Survival curves for treatments and populations. Cox
regression on survival depending on treatment and population. The
blue line represents the Itraconazole treatment for all populations.
Yellow=infected handled, red=infected unhandled. Continuous line=
population BLI, dashed line=population BLZ, dotted line=population
SGA.
doi:10.1371/journal.pone.0010927.g002
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metamorphosis (Gosner stage 42), at the end of metamorphosis (Gosner stage 46) and at the end of the experiment or death. Grey boxes=survivors,
white boxes=non-survivors. The black line represents the median, the box represents the interquartile range containing 50% of the values, and
whiskers mark the 1.5 fold interquartile range. Outliers are marked with circles. Grey boxes=survivors, white boxes=non-survivors.
doi:10.1371/journal.pone.0010927.g003
Table 1. Summary of the results of the Cox regression survival analysis of the two treatments with infected individuals.
Mean±SD Test statistic
Source of variation Survivors Non-survivors coef exp(coef) se(coef) z p
Population - - 4.37 244.10 1.05 4.03 0.000
Mass beginning 1.3160.33 1.3760.41 25.18 0.01 1.83 22.83 0.005
Mass stage 42 (g) 1.7260.29 1.6960.31 2.71 15.00 1.33 2.04 0.041
Mass stage 46 (g) 0.9860.30 0.9660.22 21.62 0.20 1.50 21.08 0.280
Mass end (g) 1.3660.28 0.9360.29 21.06 0.35 0.79 21.35 0.180
Time to stage 42 (days) 64.84631.59 52.85613.13 0.00 1.00 0.00 20.04 0.970
Time from stage 42 to 46 (days) 12.8762.81 12.2862.58 0.00 1.00 0.00 3.41 0.001
Zoospore load beginning (GE) 661.2062081.79 677.7961008.66 0.00 1.00 0.00 2.49 0.013
Zoospore load stage 46 (GE) 155.966376.63 8496.52623779.21 20.04 0.96 0.02 22.22 0.027
Zoospore load end (GE) 28.196113.21 9700.93621726.15 0.00 1.00 0.07 20.01 0.990
Population*zoospore load stage 46 - - 0.00 1.00 0.00 23.36 0.001
Population*zoospore load end - - 0.00 1.00 0.00 22.44 0.016
Mean values and Cox proportional hazard test results analysing the impact of body mass at the beginning, at Gosner stages 42, 46 and at the end of experiment, time to
and trough metamorphosis and zoospore load (genomic equivalents, GE) at the beginning, stage 46 and the end of the experiment.
doi:10.1371/journal.pone.0010927.t001
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differed in the duration of metamorphosis (Table 1). Duration of
metamorphosis may be an important determinant of how quickly
the immune system recovers after metamorphosis [32]. A better
understanding of how duration of metamorphosis affects Bd-
associated mortality would be a worthwhile topic for further study.
Variation in mass and survival may have been caused by
differential environmental conditions early in the larval stage, by
variation in the tadpole immune system (i.e. genetic variation at
disease resistance or tolerance loci, antimicrobial peptides and
symbiotic bacteria), because of differences between Bd strains from
the tadpoles’ sites of origin or because of infection of single vs.
multiple Bd strains.
We do not expect that environmental conditions experienced
early in life affected the outcome of the experiment. The tadpoles
were captured after hibernation. We kept them in the laboratory
under common garden conditions for 4 to 18 weeks before they
started metamorphosis. Because effects of previously experienced
environmental conditions often fade out quickly [41] and because
the common conditions in the laboratory experiment would
minimise environmental variation, the effects of previously
experienced environmental conditions in the ponds of origin
should be minimal.
The immunocompetence is likely to have varied among
individuals and populations. While we know little about the
genetic basis of the immune system in amphibians [42], we know
that antimicrobial peptides and symbiotic bacteria that are active
against Bd may vary both among individuals and populations
[43,44]. Strains of Bd are known to differ in how much mortality
they inflict on amphibians [45] and multiple strains of Bd may
occur within the same locality [21,46]. Infection with multiple
strains might affect virulence [47,48]. We did not test whether
tadpoles in our experiment had the same Bd strain(s), antimicrobial
peptides, or bacteria. We know, however, that the bacterial
communities differ between the populations BLI and BLZ (L.
Davis, personal communication).Whether and how the bacterial
communities found at each site differ in their Bd-inhibitory effects
is the subject of current research (L. Davis, personal communi-
cation). For logistic reasons during experimental work, the same
equipment was used for water changes for all populations within
one treatment, and thus bacterial communities and pathogen
strains may have been homogenised. Nevertheless, skin microbiota
may account for some of the variation in survival that we observed
[22]. We suggest that some of the variation in mortality among
populations that we observed in the common garden experiment is
due to genetic differences among populations. This is the usual
interpretation of among-population variation in common garden
experiments. Two lines of evidence support this suggestion. First,
we know that the host populations are genetically differentiated
(pairwise FST based on 12 microsatellites $0.19, U. Tobler & B.
Figure 4. Infection loads of surviving and non-surviving individuals. Infection load, measured in genomic equivalents from rt-PCR reactions
and logarithmically transformed, in individuals from the infected treatments at the end of experiment. The black line represents the median, the box
represents the interquartile range containing 50% of the values, and whiskers mark the 1.5 fold interquartile range. Outliers are marked with circles.
Grey boxes=survivors, white boxes=non-survivors.
doi:10.1371/journal.pone.0010927.g004
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growth (mass at metamorphosis) did affect survival; among-
population variation in life history traits can have a genetic basis
[49]. Considering this, genetic differences among populations may
at least partially explain the observed differences in mortality, as it
is often the case in host-parasite associations [50,51].
A number of experimental studies reported that many Bd-
infected amphibians can survive or even clear infection (see
electronic appendix to reference [7]). For example, Fisher et al.
[45] reported that host survival varied in a dose-dependent
manner among Bd strains. In most cases, a substantial proportion
of hosts survived (as in our experiment; Figure 1). Nevertheless, Bd
imposes strong selection on amphibian hosts. If variation in
susceptibility to Bd has a genetic basis, we would expect to see
genetic changes in the host population and ultimately the
evolution of resistance or tolerance to Bd [16,52,53]. Such
pathogen-mediated selection is known to occur in amphibians:
Tennessen and Blouin [44] and Teacher et al. [54] showed that
there is natural selection on the genetic diversity of antimicrobial
peptides and MHC alleles, respectively. One interpretation of
among-population variation in Bd-associated mortality reported in
Figure 1 is that the populations we studied may already differ in
their degree of tolerance or resistance to Bd.
While strategies to manage Bd in the wild are still being
developed [3,7], we suggest that enhancing an evolutionary
response of amphibians to Bd, may be a worthwhile conservation
strategy to mitigate the effects of the disease [55]. The model by
Briggs et al. [13] suggests that amphibian populations can persist
or even recover if some individuals loose the infection. Such a
‘‘waiting for resistance or tolerance to evolve’’ strategy may be
risky, however, as some hosts may fail to evolve adaptations to
novel pathogens [18]. First, rapid disease emergence may cause
amphibian populations to go extinct in many places before
resistance or tolerance allowing for population persistence can
evolve [18,56,57]. Second, Bd is likely to evolve counteradapta-
tions to host resistance [45]. Yet, if Bd and amphibian hosts would
enter a coevolutionary process, then extinction–as commonly
observed in areas where Bd emerged–may become a less likely
outcome.
In summary, our experiment demonstrates that within a species,
mortality can greatly differ both at the population and individual
level, and that these different mortalities are not necessarily due to
climatic variation at the time of metamorphosis because in this
case they were observed under stable laboratory conditions. The
results also show that Bd-associated mortality can be substantial in
an area where Bd is widespread ([27,28], U. Tobler and B. R.
Schmidt, unpublished data) but where no mass mortalities or Bd-
associated population declines have been reported [26]. Never-
theless, the high mortality rates we observed are likely to affect
populations and suggest that Bd may be a cryptic driver of
amphibian population dynamics. The mechanisms how amphib-
ian populations can cope with additional mortality due to
chytridiomycosis are unknown. We argue that in many situations,
global or local extinction will only occur if aided by other threats
such as habitat degradation, demographic stochasticity or unusual
weather conditions. We suggest that conservation measures should
prioritise populations that have high resistance or tolerance against
chytridiomycosis to prevent the loss of these populations by other
threats. In the long term it is desirable to determine what factors
are involved in population level disease resistance or tolerance in
order to allow the transfer of resistance mechanisms, such as
resistant genotypes or symbiotic skin microbiota, into non-resistant
populations. This may enable the management of amphibian
populations, or their habitat, to increase survival rates and thus
allow long-term population survival in the presence of novel
disease threats.
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